Adequate vitamin D intake may help maintain bone mineral density in breast cancer patients
It is well known that the major biologic function of vitamin D is to maintain normal blood levels of calcium and phosphorus. Vitamin D aids in the absorption of calcium, helping to form and maintain strong bones. Recent data have also linked low vitamin D levels to a wide range of diseases, including cancer, cardiovascular disease and autoimmune diseases.
Previous research has indicated that adequate levels of vitamin D should be maintained for the prevention and treatment of various diseases. Vitamin D supplementation is the best method to optimize vitamin D levels. A recent study on breast cancer patients has suggested that high dose vitamin D supplements are better than those providing a low dose of vitamin D.
This retrospective study involved 224 women diagnosed with stage 0-III breast cancer. Vitamin D deficiency and insufficiency were quite common in this population (66.5%), and supplementation with vitamin D was associated with significant increases in 25(OH)D levels.
Subjects received either no vitamin D supplementation; “low dose” supplementation, consisting of 1,000 IU/d vitamin D; or “high-dose” supplementation, consisting of at least 50,000 IU/d vitamin D. 25(OH)D was reassessed in the following 8-16 weeks.
High dose supplementation was associated with significantly increased 25(OH)D levels, while low-dose supplementation did not significantly increase those levels. Low vitamin D status was associated with reduced BMD in the spine.
Our product Vitamin D10 provides 10,000 IU of vitamin D3 in natural pulsed dose. Supplementation with D10 will sufficiently increase 25-OH Vitamin D to optimal levels within three months of therapy.
For more details, visit our products page.

